Welcome to our dedicated page for SHL Telemedicine American SEC filings (Ticker: SHLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SHL Telemedicine American's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SHL Telemedicine American's regulatory disclosures and financial reporting.
SHL Telemedicine Ltd. furnished a Form 6-K highlighting a September 11, 2025 press release that presents its 2025 half-year results and states that the company targets a capital raise. The press release also includes forward-looking statements along with cautionary language about factors that could cause actual results to differ.
SHL Telemedicine Ltd. furnished a current report for August 2025 noting that it issued a press release on August 12, 2025. The press release, titled “SHL announces invitation to a Special General Meeting,” is attached as Exhibit 99.1 for shareholders and market participants to review.